Chronic Kidney Disease Trial, Recruiting NCT07007338 Sponsor: Hospices Civils de Lyon Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT07007338
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children between 3 and 17 years of age
  • Children who are currently receiving ongoing dialysis treatment (hemodialysis, hemodiafiltration, or peritoneal dialysis)
  • Children whose treating doctor has decided to start them on a medication called cinacalcet, in line with 2019 European medical guidelines
  • Children with a normal heart rhythm result on an electrocardiogram (ECG) test
  • Children with a total blood calcium level above 2.40 mmol/L
  • Children with a haemoglobin (red blood cell) level above 8 g/dL
  • Children whose parents or legal guardians have not objected to participation

Who may not be able to join:

  • Children who weigh less than 12 kilograms
  • People who are currently held under a court or government-ordered restriction of liberty
  • People who are currently receiving psychiatric care
  • People who are staying in a health or social care facility for a reason other than taking part in research
  • People who are not covered by a social security or equivalent health insurance scheme
  • People who are currently within an exclusion period from another interventional research study
  • Children who have already received cinacalcet within the 3 months before joining the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: BACCHETTA Justine, MD, Hospices Civils de Lyon

Phone: 0033427856178

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
29 April 2026
Est. completion
1 August 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

value of isotope ratios of calcium (44/42 Ca) in blood

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov